Zhou Hai-Jun, Pham Lan V, Tamayo Archito T, Lin-Lee Yen-Chiu, Fu Lingchen, Yoshimura Linda C, Ford Richard J
Department of Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Blood. 2007 Sep 15;110(6):2121-7. doi: 10.1182/blood-2007-02-073080. Epub 2007 Jun 13.
CD40 is an integral plasma membrane-associated member of the TNF receptor family that has recently been shown to also reside in the nucleus of both normal B cells and large B-cell lymphoma (LBCL) cells. However, the physiological function of CD40 in the B-cell nucleus has not been examined. In this study, we demonstrate that nuclear CD40 interacts with the NF-kappaB protein c-Rel, but not p65, in LBCL cells. Nuclear CD40 forms complexes with c-Rel on the promoters of NF-kappaB target genes, CD154, BLyS/BAFF, and Bfl-1/A1, in various LBCL cell lines. Wild-type CD40, but not NLS-mutated CD40, further enhances c-Rel-mediated Blys promoter activation as well as proliferation in LBCL cells. Studies in normal B cells and LBCL patient cells further support a nuclear transcriptional function for CD40 and c-Rel. Cooperation between nuclear CD40 and c-Rel appears to be important in regulating cell growth and survival genes involved in lymphoma cell proliferation and survival mechanisms. Modulating the nuclear function of CD40 and c-Rel could reveal new mechanisms in LBCL pathophysiology and provide potential new targets for lymphoma therapy.
CD40是肿瘤坏死因子受体家族的一个与质膜相关的整合成员,最近研究表明它也存在于正常B细胞和大B细胞淋巴瘤(LBCL)细胞的细胞核中。然而,CD40在B细胞核中的生理功能尚未得到研究。在本研究中,我们证明在LBCL细胞中,细胞核中的CD40与核因子-κB蛋白c-Rel相互作用,但不与p65相互作用。在各种LBCL细胞系中,细胞核中的CD40与c-Rel在核因子-κB靶基因CD154、B淋巴细胞刺激因子/增殖诱导配体(BLyS/BAFF)和Bfl-1/A1的启动子上形成复合物。野生型CD40,而非核定位信号(NLS)突变的CD40,进一步增强了c-Rel介导的Blys启动子激活以及LBCL细胞的增殖。对正常B细胞和LBCL患者细胞的研究进一步支持了CD40和c-Rel的核转录功能。细胞核中的CD40与c-Rel之间的合作在调节参与淋巴瘤细胞增殖和存活机制的细胞生长和存活基因方面似乎很重要。调节CD40和c-Rel的核功能可能揭示LBCL病理生理学的新机制,并为淋巴瘤治疗提供潜在的新靶点。